John A. Blessing

Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group study

Francis J. Major, John A. Blessing, Steven G. Silverberg et al. · Cancer · 1993 · 663 citations · Full text

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

David H. Moore, John A. Blessing, Richard P. McQuellon et al. · Journal of Clinical Oncology · 2004 · 634 citations · Full text

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Philip Bonomi, John A. Blessing, Frederick B. Stehman et al. · Journal of Clinical Oncology · 1985 · 404 citations

Cancer Management, Gynecology, Randomized Prospective Trial +20

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

Peter G. Rose, John A. Blessing, Andrew R. Mayer et al. · Journal of Clinical Oncology · 1998 · 402 citations

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.

G A Omura, John A. Blessing, Francis J. Major et al. · Journal of Clinical Oncology · 1985 · 393 citations

Uterine Sarcomas, Randomized Clinical Trial, Surgical Oncology +14